These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 3567373)
1. [Sequential administration of methotrexate and 5-fluorouracil in epidermoid carcinomas of the head and neck. Results of a prospective study]. Chevallier B; Lefur R; Dehesdin D; Bastit P; Seng SH Bull Cancer; 1986; 73(6):680-2. PubMed ID: 3567373 [No Abstract] [Full Text] [Related]
2. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Katori H; Tsukuda M; Taguchi T Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926 [TBL] [Abstract][Full Text] [Related]
3. Use of methotrexate and 5-FU for recurrent head and neck cancer. Jacobs C Cancer Treat Rep; 1982 Nov; 66(11):1925-8. PubMed ID: 6754074 [TBL] [Abstract][Full Text] [Related]
4. [Adjuvant chemotherapy in advanced squamous cell carcinoma of the head and neck]. Zhou T; Zeng Z Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(3):171-3. PubMed ID: 8579878 [TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy for advanced squamous cell carcinoma of the head and neck. Raafat J; Oster MW Cancer Treat Rep; 1980 Jan; 64(1):187-9. PubMed ID: 6155209 [TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced epidermoid carcinoma of the head and neck using methotrexate, bleomycin and cis-platinum. Orsini MA; Strauss M; Zaino RJ; Messeih AA; Harvey HA; Lipton A Trans Pa Acad Ophthalmol Otolaryngol; 1984; 37(1):71-6. PubMed ID: 6204427 [No Abstract] [Full Text] [Related]
7. Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck. Faivre S; Marti A; Rixe O; Janot F; Julieron M; Gatineau M; Temam S; Armand JP; Domenge C; Luboinski B; Raymond E Head Neck; 2005 Apr; 27(4):311-9. PubMed ID: 15700290 [TBL] [Abstract][Full Text] [Related]
8. Integration of safe initial combination chemotherapy (without cisplatin) with a high response rate and local therapy for untreated stage III and IV epidermoid cancer of the head and neck: 5-year survival data. Price LA; MacRae K; Hill BT Cancer Treat Rep; 1983 Jun; 67(6):535-9. PubMed ID: 6190557 [TBL] [Abstract][Full Text] [Related]
9. Intra-arterial infusion for head and neck cancers. Geriatrics; 1973 Jul; 28(7):118-9. PubMed ID: 4575888 [No Abstract] [Full Text] [Related]
10. [A case of head and neck squamous cell carcinoma suffering from acute renal failure after methotrexate administrator]. Nagao J; Tsukuda M; Yoshida T; Sakuma N; Matsuda H; Mikami Y Gan To Kagaku Ryoho; 2005 Jun; 32(6):821-3. PubMed ID: 15984523 [TBL] [Abstract][Full Text] [Related]
11. Improved therapeutic index of methotrexate with "leucovorin rescue". Levitt M; Mosher MB; DeConti RC; Farber LR; Skeel RT; Marsh JC; Mitchell MS; Papac RJ; Thomas ED; Bertino JR Cancer Res; 1973 Jul; 33(7):1729-34. PubMed ID: 4541737 [No Abstract] [Full Text] [Related]
12. Epidermoid carcinoma of head and neck: high-dose methotrexate in preoperative management. Arlen M N Y State J Med; 1979 Aug; 79(9):1384-9. PubMed ID: 291799 [No Abstract] [Full Text] [Related]
13. Clinical randomized study of 5FU monitoring versus standard dose in patients with head and neck cancer: preliminary results. Fety R; Rolland F; Barberi-Heyob M; Merlin JL; Conroy T; Hardouin A; Riviere A; Milano G Anticancer Res; 1994; 14(6A):2347-52. PubMed ID: 7825970 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck. Baghi M; Hambek M; May A; Radeloff A; Gstoettner W; Knecht R Anticancer Res; 2006; 26(1B):559-63. PubMed ID: 16739320 [TBL] [Abstract][Full Text] [Related]
15. Sequential combination chemotherapy of advanced head and neck carcinoma: re-evaluation of a highly effective regimen. Veronesi A; Barzan L; Magri MD; Tirelli U; Galligioni E; Trovò MG; Tumolo S; Comoretto R; Grigoletto E Strahlentherapie; 1981 Apr; 157(4):277-9. PubMed ID: 6166105 [TBL] [Abstract][Full Text] [Related]
16. Methotrexate treatment of advanced head and neck cancers: a dose response evaluation. Woods RL; Fox RM; Tattersall MH Cancer Treat Rep; 1981; 65 Suppl 1():155-9. PubMed ID: 7034929 [TBL] [Abstract][Full Text] [Related]
17. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer. Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324 [TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy of head and neck carcinomas. Association of adriamycine, vincristine and methotrexate (author's transl)]. Durand M; Chauvergne J; Renaud-Salis JL Ann Otolaryngol Chir Cervicofac; 1980; 97(4-5):277-83. PubMed ID: 7406411 [TBL] [Abstract][Full Text] [Related]
19. Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck. Hitt R; Jimeno A; Millán JM; Castellano D; Cortés-Funes H Cancer; 2004 Aug; 101(4):768-75. PubMed ID: 15305408 [TBL] [Abstract][Full Text] [Related]
20. The use of oral methotrexate (mtx) in the treatment of tumours in the head and neck-region. Rietberg M Arch Chir Neerl; 1970; 22(2):107-16. PubMed ID: 4317753 [No Abstract] [Full Text] [Related] [Next] [New Search]